A Lesson from Enron

A Lesson from Enron Nicholas Wade's article, "Fraud Happens: What to Do About It,"1 touches on several aspects of the phenomenon of scientific fraud in the wake of Jan Henrik Schon's scandal at Bell Labs. However, I found myself a bit disappointed reading about actions and checkpoints that do not work in curbing fraud in science and not much in terms of "what to do about it." Although an attempt was made to shift the responsibility of fraud detection to the lab chief, in many cases the chie

Written byAvital Schurr
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Nicholas Wade's article, "Fraud Happens: What to Do About It,"1 touches on several aspects of the phenomenon of scientific fraud in the wake of Jan Henrik Schon's scandal at Bell Labs. However, I found myself a bit disappointed reading about actions and checkpoints that do not work in curbing fraud in science and not much in terms of "what to do about it." Although an attempt was made to shift the responsibility of fraud detection to the lab chief, in many cases the chief himself is the perpetrator. Moreover, in today's rich and expensive science where a whole institution can rise or fall on one fat grant, self-policing is frequently used to silence a whistleblower rather than expose and punish a perpetrator.

Maybe science should take a page from the recent book of fraudulent activities in big corporations such as Enron and WorldCom, where whistle-blowing has been responsible for exposing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies